Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015)
Enanta Pharmaceuticals' (ENTA) quarterly Minority Interest came in at $164000.0 in Q4 2015, up 0.61% on a QoQ basis from $163000.0 in Q3 2015.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 2 years of Minority Interest data on file, last reported at $164000.0 in Q4 2015.
- Quarterly Minority Interest changed N/A year-over-year to $164000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $164000.0 (changed N/A YoY) and the FY2015 annual result came in at $163000.0, down 19.31% from the prior year.
- Minority Interest grew to $164000.0 in Q4 2015, from $163000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $202000.0 in Q3 2014 to a low of $163000.0 in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 409.30 Mn | 219.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 164,000.00 |
| Sep 30, 2015 | 163,000.00 |
| Jun 30, 2015 | 185,000.00 |
| Sep 30, 2014 | 202,000.00 |